"It's outrageous. It's stupid. It's unreasonable, to be frankly honest with you."
That is Marvin Jung, a 51-year-old regional director of operations in veterinary care, describing SpaceX's valuation to CNBC. In the same breath, he requested 1,000 shares through Robinhood.
He isn't confused. He's the whole market in miniature.
That gap — between what buyers say and what they do — is not a psychological quirk. It's the raw material these products are built to monetize.
Jung doesn't want to own SpaceX. He wants to sell it "shortly after trading begins," free up cash for Anthropic and OpenAI, and get back some of what he "spent on my wife's Tesla." He calls the deal "a beautiful symphony of all the right trigger meme words" and guesses a 30% first-day pop. The disbelief and the buy order coexist without friction.
That gap — between what buyers say and what they do — is not a psychological quirk this week's product launches have to overcome. It's the raw material they're built to monetize.
Last week we tracked the SpaceX IPO slide as it dragged the whole private-space complex into public markets. This week the machinery matures: the first pure-play fusion listing arrives, and a fresh crop of packaged retail products lands, each one engineered to turn "the fundamentals aren't proven" from a reason to wait into a reason to buy now.
Start with the rules, because rules are supposed to be the slow-moving part.
Ahead of the June 12 debut, Nasdaq Global Indexes shelved its low-float requirement and cut the time a megacap needs to qualify for Nasdaq-100 inclusion from roughly three months to just 15 trading days. The Russell series made a parallel move — large-cap IPOs now eligible after five sessions instead of a quarterly review.
These are investor-protection rules, and they were amended in the direction of less protection, right before the largest IPO in history.
The effect is mechanical. Index funds, mutual funds and 401(k)s are now forced to buy SpaceX within days — spending tens of billions on a stock they didn't choose, at whatever price the tape prints.
Now add the float. SpaceX sold only about 555.6 million shares — a little over 4% of shares outstanding, against the 10%-plus most IPOs float.
Put those two facts together and you get a designed squeeze: a tiny supply of stock, chased by a wall of buyers contractually required to show up. The price that results isn't discovery. It's plumbing.
And the reckoning has a date. SpaceX's staggered unlock reportedly begins in August, when insiders sitting on enormous private-market gains finally get to sell into the funds and retail holders who bought the forced rally.
The structure front-loads the buying and back-loads the selling. Guess which side the last buyer is on.
Then, on IPO day itself, ProShares launched Ultra SpaceX, a single-stock ETF targeting 2x the daily return, at a 0.95% expense ratio. Leveraged single-stock funds carry volatility decay from daily resetting — you can be right on direction and still lose money — which is why they're tools for gamblers, not holders. Same-day launch, same engineered impatience.
Korea supplied the most inventive vehicle. On July 7 — the day SpaceX officially joined the Nasdaq-100 — Kiwoom listed its "US Space Tech TOP2 Bond Mixed 50" ETF: 25% SpaceX, 25% Rocket Lab, 50% Korean short-term government and stabilization bonds, rebalanced daily.
The bond half isn't there for yield. It's there for classification.
Because the fund is bond-mixed, it counts as a non-risk asset for Korean retirement pensions — meaning it can go up to 100% into IRP and DC accounts. Investors who've already maxed the 70% risky-asset limit can pour the remaining 30% into this, pushing effective equity exposure as high as 85%.
Read that slowly. A wrapper of Korean government bonds is being used to smuggle an unlisted American rocket company past the risk limits that guard retirement savings. The safest possible label, bolted onto one of the most speculative possible holdings.
And the holdings themselves are not cheap. Rocket Lab reportedly trades near $50 billion on roughly $680 million in trailing revenue — a 73x sales multiple — while burning $316 million in free cash flow over the trailing twelve months, with an operating margin of minus 33%.
That valuation isn't priced on what Rocket Lab does. It's priced, per AInvest, on Neutron, the medium-lift rocket meant to rival Falcon 9, launching successfully — a debut already pushed to no earlier than Q4 2026 after a test failure.
So the retirement-account buyer is underwriting a rocket that hasn't flown, via a fund labeled non-risky, enabled by index rules that were loosened to force the buying in the first place. Each layer moves the risk one step further from the people who understand it.
Which brings us to the newest arrival, and the purest expression of the pattern.
This week General Fusion cleared shareholder approval to merge with Spring Valley Acquisition Corp. III and list on Nasdaq — becoming, per the announcement, the first pure-play fusion company to trade publicly. The vehicle is a SPAC: the structure famous for letting companies sell projections in place of revenue.
That distinction matters here more than anywhere. As our sibling piece on fusion hardware reportedly lays out, neither China nor the US has demonstrated net-energy breakeven — the basic physics of getting more energy out than you put in remains unsolved.
A SPAC is precisely the instrument that lets retail buy exposure to that unsolved problem today. The whole point of the wrapper is that it doesn't require the product to exist yet — only a story about when it might.
Notice how consistent the design is across all of it.
An IPO with no proven public-market earnings. A proxy stock at 73x sales on a rocket that hasn't flown. A leveraged fund that decays if you hold it. A retirement product that hides a rocket bet inside a bond label. A fusion company selling a future that violates no law of physics except the one that says it has to work first.
Every structure prices a future that hasn't arrived. And every structural choice — low float, accelerated inclusion, leverage, retirement eligibility, the SPAC itself — does the same quiet work: it moves the moment of reckoning onto someone else's calendar.
The reckoning still comes. It's just been relocated.
It arrives at the August lock-up expiry, when insiders sell. At Neutron's first flight, whenever that finally happens. At net-energy breakeven, if it ever does. Those are the moments when the story either becomes a business or doesn't.
The financial engineering can't change whether those events succeed. It can only change who is holding the position when they occur.
Marvin Jung understood his end of the trade perfectly — pop, flip, gone before day two. The danger was never for the buyer who calls the valuation stupid and plans his exit.
It's for the one who bought the same exposure through a bond-mixed retirement wrapper, and thinks the label means he's safe.